Table 2 Changes in clinical parameters, risk factors and lifestyle measures over the study year.

From: Changes in natural killer and T lymphocyte phenotypes in response to cardiovascular risk management

 

Baseline

Follow-up

Difference

P

Clinical data (N, %)

 Weight (kg)

81.2 (± 15.1)

80.7 (± 15.0)

− 0.5 (± 2.7)

0.248

 Waist (cm)

100 (± 12.7)

100 (± 12.2)

− 0.1 (± 3.0)

0.887

 BMI

28.4 (± 4.3)

28.2 (± 4.6)

+ 0.2 (± 1.8)

0.456

 Systolic blood pressurea (mmHg)

150 (± 18)

143 (± 19)

− 6.3 (± 19.7)

0.028

 Diastolic blood pressurea (mmHg)

84.2 (± 9.2)

81.1 (± 9.4)

− 3.1 (± 7.7)

0.006

 Systolic home pressure (mmHg)

135 (± 13)

130 (± 13)

− 4.8 (± 9.9)

0.010

 Diastolic home pressure (mmHg)

76 (± 6)

74 (± 7)

− 2.2 (± 5.1)

0.019

 Frailty score

3.5 (± 0.6)

3.4 (± 1.0)

− 0.1 (± 1.0)

0.673

Risk factors (N, %)

 Active smoking

7 (14)

6 (12)

− 1 (2)

0.794

 Systolic blood pressure > 140 mmHg

36 (62)

29 (58)

− 7 (14)

0.499

 LDL > 1.8

33 (66)

24 (48)

− 9 (18)

0.341

 HbA1c > 53 mmol/mol

7 (14)

4 (8)

− 3 (6)

0.390

Levels of physical exercise

 No physical activity

10 (20)

14 (28)

 + 4 (8)

0.463

 Limited physical activity

27 (54)

23 (46)

− 4 (8)

0.644

 Regular physical exercise

10 (20)

11 (22)

+ 1 (2)

0.843

 Consistent physical exercise

3 (6)

2 (4)

− 1 (2)

0.663

  1. Changes in risk factors and lifestyle measures for the 50 patients in the study. Data for levels of physical exercise were based on a questionnaire, filled in by the clinician during the patient interview at baseline and follow-up visits.
  2. aRight arm, sitting position.